发明名称 |
Use of oritavancin for prevention and treatment of anthrax |
摘要 |
Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against B. anthracis. Methods for the treatment, prophylaxis and prevention of B. anthracis infection and disease in animals, including humans, are described. |
申请公布号 |
US9089507(B2) |
申请公布日期 |
2015.07.28 |
申请号 |
US200712442751 |
申请日期 |
2007.09.24 |
申请人 |
THE MEDICINES COMPANY |
发明人 |
Moeck Gregory;Parr, Jr. Thomas Reeves |
分类号 |
A61K38/14;A61K31/00;A61K31/7052 |
主分类号 |
A61K38/14 |
代理机构 |
Roylance, Abrams, Berdo & Goodman, L.L.P. |
代理人 |
Roylance, Abrams, Berdo & Goodman, L.L.P. |
主权项 |
1. A method of preventing a B. anthracis infection in a subject, consisting of administering to a subject at risk of exposure to B. anthracis one or more antibiotics in an amount sufficient to prevent B. anthracis infection, wherein the one or more antibiotics includes oritavancin, or a pharmaceutically acceptable salt, or hydrate thereof, or a mixture thereof, thereby preventing a B. anthracis infection in a subject. |
地址 |
Parsippany NJ US |